STAGE IV LIVER CANCER
Clinical trials for STAGE IV LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LIVER CANCER trials appear
Sign up with your email to follow new studies for STAGE IV LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail shows promise for tough liver cancer
Disease control OngoingThis study tests if adding two immunotherapy drugs (atezolizumab and bevacizumab) to standard chemotherapy works better than chemo plus one immunotherapy for advanced liver cancer that can't be removed surgically. About 88 adults with a specific type of liver cancer will take par…
Matched conditions: STAGE IV LIVER CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New drug combo aims to boost Radiation's punch against tough GI cancers
Symptom relief OngoingThis early-phase study tested an oral drug called ropidoxuridine (IPdR) in 19 people with advanced gastrointestinal cancers that could not be cured. The goal was to find the safest dose and see if the drug could make tumor cells more sensitive to radiation therapy. The study focu…
Matched conditions: STAGE IV LIVER CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 17, 2026 04:15 UTC
-
One-Day liver cancer treatment shows promise in early trial
Symptom relief OngoingThis early-phase study tests whether a liver cancer treatment called Y90 radioembolization can be safely done in a single session instead of the usual two-day process. The treatment uses tiny radioactive beads injected into the liver's blood supply to shrink tumors. Researchers w…
Matched conditions: STAGE IV LIVER CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC